Tasmania Selects Epic for Statewide EMR Implementation Epic Systems has been chosen as the provider for Tasmania’s statewide Electronic Medical…
Browsing: phase
Targeted therapy has shown promising results in a Phase I trial for patients with certain genetic defects. The therapy, known…
The FDA has recently announced a groundbreaking agreement with the food industry to phase out petroleum-based artificial dyes commonly used…
Food manufacturers in the United States have made a significant announcement that they will be phasing out eight synthetic dyes…
The U.S. Food and Drug Administration (FDA) has made a groundbreaking announcement regarding the development of monoclonal antibody therapies and…
Glioblastoma is a devastating form of brain cancer that has a poor prognosis, with an average survival of only 15-18…
Researchers at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai have recently conducted a groundbreaking…
